Description
Product name: Ursodeoxycholic Acid
Alias: 3alpha, 7beta*5beta cholestane - *4 - acid
CAS No.: *******2
MF: C*4H*0O4
MW: **2.*8
Packing detail: 1KG / aluminum foil bag
Content: Ursodeoxycholic acid in human bile in gallbladder
accounted for a few. After oral administration of ursodeoxycholic
acid, through the inhibition of cholesterol in the intestine
reabsorption and lower cholesterol to bile secretion, and thereby
reduces biliary cholesterol saturation. May be due to cholesterol
dispersion and liquid crystal formation, and the cholesterol
gallstones gradually dissolve. On the basis of the existing
knowledge, ursodeoxycholic acid capsules for treatment of liver and
bile stasis disease is mainly based on the hydrophilic, have a
cytoprotective effect and no cell toxicity of ursodeoxycholic acid
relative to alternative lipophilic, decontamination agent kind on
the toxicity of bile acids, and promote liver cell secretion
function and immune regulation to accomplish the.
Physical Character: This medicine can promote endogenous bile
acid secretion, reduce reabsorption; antagonistic hydrophobic bile
acid cytotoxicity, protecting liver cell membrane; dissolving
cholesterol calculus; and to have immunomodulatory effects
Melting point: **0 ～**4℃
Usage: Applicable to the prevention and treatment of cholesterol
gallstones
